한글목차

신경외과, 치과, 정형외과의 각 시장에서의 기회에 의해 세계의 골결손 수복재 시장 미래는 유망시되고 있습니다. 세계의 골결손 수복재 시장은 2025-2031년 연평균 복합 성장률(CAGR) 12.6%를 나타낼 것으로 예측됩니다. 이 시장의 주요 촉진요인은 뼈 관련 질병의 이환율 증가, 첨단 뼈 복구 기술에 대한 수요 증가, 낮은 침습 수술 채택 증가입니다.

• Lucintel사의 예측에서는 유형별로는 자가골이 예측기간 중에 가장 높은 성장을 이룰 전망입니다.
• 용도별로는 정형외과가 가장 높은 성장이 예상되고 있습니다.
• 지역별로는 북미가 예측기간 동안 가장 높은 성장이 예상됩니다.

150페이지 이상의 종합적인 보고서를 통해 비즈니스 의사 결정에 도움이 되는 귀중한 인사이트를 얻을 수 있습니다. 몇 가지 인사이트를 포함하는 샘플 다이어그램이 아래에 나와 있습니다.

골결손 수복재 시장 새로운 동향

골결손 수복재 시장은 현재 골 재생을 적극적으로 촉진하고 숙주 조직의 필수적인 부분이 되는 재료에 대한 수요 증가를 반영하는 몇 가지 주요 동향의 영향을 받고 있습니다.

• 뼈의 자연 구조를 닮은 생체 모방형 비계의 설계 : 주요 동향의 하나는 자연골의 복잡한 조성과 구조를 모방한 생체 모방형 비계의 설계와 제조입니다. 일반적으로 하이드록시아파타이트와 콜라겐과 같은 재료로 만들어진 이 스캐폴드는 세포의 접착, 증식, 분화를 가능하게 하고 뼈 재생을 촉진합니다.
• 성장 인자의 도입에 의한 골 유도성의 향상 : 골 이식재에 골 형태 형성 단백질(BMP) 및 기타 성장 인자와 같은 생물활성 약물을 포함하는 이용이 증가하고 있습니다. 이 약물은 간엽 줄기 세포에서 골아 세포로의 분화를 직접 유도하고 골 융합 과정을 가속화하고 결함 부위에 성공적으로 채우는 비율을 높입니다.
• 환자 특이적 골 이식에 있어서의 3D 프린팅의 개발 : 3D 프린팅 기술의 이용 확대에 의해 결손부와 같은 사이즈·형상의 환자 특이적 골 이식편의 개발이 가능하게 되었습니다. 개인화는 특히 복잡한 골결손에서 이식편의 적합성을 높이고 수술 시간을 단축하며 기능적 결과를 향상시킬 수 있습니다.
• 주사가능하고 낮은 침습성 전달 시스템 : 주입 가능한 뼈 이식 재료와 침습성이 낮은 전달 시스템이 인기를 끌고 있습니다. 이 방법은 엄청난 수술을 줄이고 연조직의 외상을 최소화하고 복잡한 모양의 뼈 결손을 정확하게 채울 수 있으므로 회복이 빠르고 이환율도 낮습니다.
• 세포 기반 치료와 스캐폴드 재료의 시너지 효과 : 중간엽 줄기세포(MSCs)와 같은 세포 기반 치료와 골 이식용 스캐폴드의 조합은 새로운 경향입니다. 자가 또는 동종 MSC를 스캐폴드에 파종함으로써 결핍 부위의 골 형성 세포의 국소적 공급원이 되어 골 재생이 더욱 촉진됩니다.

이러한 새로운 동향은 침습성이 낮고 생물학적으로 활성이며 보다 개별화된 솔루션으로 골결손 수복재 시장을 개혁하고 있습니다. 생체모방형 스캐폴드, 생물활성제, 3D 프린팅, 주사 시스템, 세포 기반 요법에 중점을 두는 것은 골결손 수복의 속도, 효능, 예측 가능성을 높이는 것을 의도하고, 그 결과 환자의 결과가 개선될 것입니다.

골결손 수복재 시장 최근 동향

골결손 수복재 시장은 최근 몇 가지 중요한 동향을 목격하고 있으며, 이러한 물질의 재생 능력과 임상 유용성을 향상시키기 위해 노력하고 있습니다.

• 약물전달 기능을 갖춘 스마트 골 이식재의 창출 : 최근의 기술 혁신 중에는 약제를 국소적으로 딜리버리할 수 있는 골 이식재, 즉, 감염을 피하기 위한 항생제나, 수술 후의 염증을 최소한으로 억제하기 위한 항염증제 등을, 결손 부위에 직접 딜리버리할 수 있는 골 이식재가 있어,
• 오세오 통합 강화를 위한 표면 개질 방법의 신개발 : 과학자들은 숙주 골 조직과의 더 나은 상호작용을 촉진하고, 오세오 통합을 개선하고, 복구된 뼈의 장기적인 안정성을 보장하기 위해 골 이식 재료의 표면 개질에 집중하고 있습니다.
• 뛰어난 생리활성을 가진 합성 생체재료의 신규 도입 : 표준 인산칼슘을 넘는 새로운 합성 생체재료는 보다 양호한 골 재생을 위해, 보다 높은 생물학적 활성과 보다 자연적인 골 흡수 턴오버와 일치하는 분해 특성을 갖도록 합성됩니다.
• 제어 방출 성장 인자 용출 스캐폴드의 개발 : 성장 인자를 장기간에 걸쳐 제어·지속적으로 방출하고, 치료 효과를 극대화하고, 보다 효과적인 골치유를 촉진하는 비계의 개발에 있어서 큰 진보가 달성되고 있습니다.
• 조직 엔지니어링 뼈 이식편의 임상 응용 : 이 이식편은 in vitro에서 스캐폴드에 세포를 성장시키고 이식하여 생체 내에서 뼈 조직을 재생시키는 것으로, 크고 복잡한 골결손에 대한 유망한 해결책이 됩니다.

골결손 수복재 시장 최근 동향은 공간을 채울 뿐만 아니라 골치유 과정에 적극적으로 관여하는 재료의 개발에 중점을 두고 있는 것으로 대표됩니다. 약물전달, 표면 개질, 새로운 생체재료, 통제된 성장 인자 방출, 조직 공학의 발전으로 보다 예측 가능하고 효과적인 골결손 복구 접근법에 대한 길을 열고 있습니다.

목차

제1장 주요 요약

제2장 세계의 골결손 수복재 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• PESTLE 분석
• 특허 분석
• 규제 환경
• 업계의 성장 촉진요인과 과제

제3장 시장 동향과 예측 분석(2019-2031년)

• 거시경제 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 골결손 수복재 시장 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 골결손 수복재 시장 : 유형별
  • 자가골 : 동향과 예측(2019-2031년)
  • 천연골 : 동향과 예측(2019-2031년)
  • 인공골 : 동향과 예측(2019-2031년)
• 세계의 골결손 수복재 시장 : 용도별
  • 신경외과 : 동향과 예측(2019-2031년)
  • 치과 : 동향과 예측(2019-2031년)
  • 정형외과 : 동향과 예측(2019-2031년)
  • 기타 : 동향과 예측(2019-2031년)

제4장 시장 동향과 예측 분석 : 지역별(2019-2031년)

• 세계의 골결손 수복재 시장 : 지역별
• 북미의 골결손 수복재 시장
• 유럽의 골결손 수복재 시장
• 아시아태평양의 골결손 수복재 시장
• 기타 지역의 골결손 수복재 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석
  • 경쟁 기업 간 경쟁 관계
  • 구매자의 협상력
  • 공급기업의 협상력
  • 대체품의 위협
  • 신규 참가업체의 위협

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 세계의 골결손 수복재 시장 성장 기회 : 유형별
  • 세계의 골결손 수복재 시장 성장 기회 : 용도별
  • 세계의 골결손 수복재 시장 성장 기회 : 지역별
• 세계의 골결손 수복재 시장 새로운 동향
• 전략 분석
  • 신제품 개발
  • 세계의 골결손 수복재 시장 생산 능력 확대
  • 세계의 골결손 수복재 시장 합병, 인수, 합작 사업
  • 인증 및 라이선싱

제7장 주요 기업의 기업 프로파일

• Stryker
• Medtronic
• Johnson & Johnson
• Olympus Terumo Biomaterials
• NovaBone Products
• Biocomposites
• Tianjin Sannie Bioengineering Technology
• ALLGENS MEDICAL
• Jiangsu Yenssen Biotech
• Shanghai Rebone Biomaterials

영문목차

The future of the global bone defeat repair material market looks promising with opportunities in the neurosurgery, dentistry, and orthopedic markets. The global bone defeat repair material market is expected to grow with a CAGR of 12.6% from 2025 to 2031. The major drivers for this market are the rising incidence of bone-related disorders, the growing demand for advanced bone repair technologies, and the increasing adoption of minimally invasive surgeries.

• Lucintel forecasts that, within the type category, autologous bone is expected to witness the highest growth over the forecast period.
• Within the application category, orthopedic is expected to witness the highest growth.
• In terms of region, North America is expected to witness the highest growth over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report. Sample figures with some insights are shown below.

Emerging Trends in the Bone Defeat Repair Material Market

The bone defeat repair material market is presently being influenced by some of the key trends that reflect the growing demand for materials that actively enhance bone regeneration and become an integral part of the host tissue.

• Designing Biomimetic Scaffolds that Resemble the Natural Structure of Bone: One key trend is designing and producing biomimetic scaffolds that emulate the intricate composition and structure of natural bone. The scaffolds, typically fabricated using materials such as hydroxyapatite and collagen, allow cells to attach, proliferate, and differentiate and hence augment bone regeneration.
• Growth Factor Incorporation for Improved Osteoinductivity: Increasing use is being made of incorporating bioactive agents like bone morphogenetic proteins (BMPs) and other growth factors into bone grafting materials. These agents directly induce the differentiation of mesenchymal stem cells into osteoblasts, speeding up the process of bone healing and enhancing the rate of success in filling defects.
• Development of 3D Printing in Patient-Specific Bone Grafts: The growing use of 3D printing technology enables the development of patient-specific bone graft scaffolds that are accurately the same size and shape as the defect. Personalization has the potential to enhance graft integration, shorten surgical duration, and improve the functional result, especially in complicated bone defects.
• Injectable and Minimally Invasive Delivery Systems: Injectable bone graft materials and minimally invasive delivery systems are gaining popularity. The methods decrease the amount of extensive surgery, minimize soft tissue trauma, and enable accurate filling of complexly shaped bone defects, resulting in quicker recovery and less morbidity.
• Synergy of Cell-Based Therapies with Scaffold Materials: The use of a combination of cell-based therapies, e.g., mesenchymal stem cells (MSCs), and bone graft scaffolds is a new trend. Seeding of scaffolds with autologous or allogeneic MSCs will further augment bone regeneration through a local source of osteogenic cells at the site of the defect.

These new trends are reforming the bone defeat repair material market towards less invasive, biologically active, and more individualized solutions. The emphasis on biomimetic scaffolds, bioactive agents, 3D printing, injectable systems, and cell-based therapies is intended to enhance the speed, efficacy, and predictability of bone defect repair, which would result in improved patient outcomes.

Recent Developments in the Bone Defeat Repair Material Market

The market for bone defeat repair material has witnessed some significant developments in the recent past, with efforts to improve the regenerative capability and clinical utility of these materials.

• Creation of Smart Bone Graft Materials with Drug Delivery Functionality: Some of the recent innovations involve the creation of bone graft materials that are capable of delivering drugs locally, i.e., antibiotics to avoid infection or anti-inflammatory drugs to minimize postoperative inflammation, directly to the site of the defect, with enhanced outcome.
• New Developments in Surface Modification Methods for Enhanced Osseointegration: Scientists are concentrating on the surface modification of bone grafting materials to facilitate better interaction with host bone tissue, ensuring improved osseointegration and long-term stability of the repaired bone.
• Novel Introduction of Synthetic Biomaterials with Superior Bioactivity: New synthetic biomaterials, more than standard calcium phosphates, are synthesized with higher bioactivity and degradability characteristics more in agreement with natural bone resorption turnover for more favorable bone regeneration.
• Controlled Release Growth Factor-Eluting Scaffolds Development: Great advances have been achieved in the development of scaffolds that release growth factors in a controlled and sustained fashion over time, maximizing their therapeutic benefit and facilitating more effective bone healing.
• Clinical Translation of Tissue-Engineered Bone Grafts: Although still in its infancy, there is growing clinical translation of tissue-engineered bone grafts, where cells are grown on scaffolds in vitro and implanted to regenerate bone tissue in vivo, providing a promising solution for large and complex bone defects.

These recent advances in the bone defeat repair material market are typified by an emphasis on developing materials that are not only space-filling but also actively engage in the process of bone healing. The advances in drug delivery, surface modification, new biomaterials, controlled growth factor release, and tissue engineering are opening up the way for more predictable and effective bone defect repair approaches.

Strategic Growth Opportunities in the Bone Defeat Repair Material Market

Bone defeat repair material market offers several strategic growth opportunities by targeting selected clinical applications and unmet needs in those domains.

• Tackling Large Bone Defects and Non-Unions: Therapy for large bone defects caused by trauma, tumor resection, or infection and difficult non-union fractures poses a large expansion opportunity for improved bone graft technologies and tissue engineering methods that will facilitate significant bone regeneration.
• Boosting Bone Regeneration in Spinal Fusion Procedures: The rising incidence of spinal fusion procedures necessitates bone graft materials that can consistently induce fusion and avoid pseudoarthrosis. Creating products with improved osteoinductive capacity and site-specific mechanical strength for spinal use is a prime opportunity.
• Enhancing Results in Dental Bone Grafting and Implantology: Bone grafting in dental implantology is frequently required to provide sufficient bone volume and density. Creating novel bone graft materials and delivery systems tailored to dental use can enhance the success rates of implants and outcomes for patients.
• Facilitating Bone Healing in Osteoporotic Fractures: Osteoporosis impairs bone healing, making fracture repair challenging. Developing bone graft materials that can enhance bone regeneration in osteoporotic bone is a significant growth opportunity, particularly with the aging global population.
• Solutions for Infected Bone Defects (Osteomyelitis): Osteomyelitis treatment frequently entails extensive bone loss. The design of bone graft materials with inherent antimicrobial activity or the capacity to locally deliver antibiotics can enhance outcomes in these difficult situations.

These strategic growth prospects in the bone defeat repair material market are in addressing specific clinical issues like large bone defects, spinal fusion, dental bone grafting, osteoporotic fractures, and infected bone defects. By creating new materials and delivery systems specific to these uses, manufacturers can meet unmet clinical needs and realize substantial market growth.

Bone Defeat Repair Material Market Driver and Challenges

The key drivers for the market for bone defeat repair material are the aging population and the consequent rise in bone injuries and diseases, technological advances in biomaterials and tissue engineering, and increased demand for successful bone regeneration therapies. On the other hand, the market is hindered by issues like the prohibitive expense of advanced materials and cell-based therapies, challenging regulatory pathways for novel bone graft products, and clinical complexity of establishing consistent bone regeneration in specific defect types.

The factors responsible for driving the bone defeat repair material market include:

1. Aging Population and Higher Occurrence of Bone Disorders: The worldwide aging population is resulting in a greater incidence of fractures, osteoporosis, and other bone disorders, thus raising the need for effective repair materials for bone defects.

2. Improved Biomaterials and Tissue Engineering: Ongoing advancement in biomaterials technology and tissue engineering is leading to the creation of increasingly effective and biocompatible bone graft materials possessing greater osteogenic capabilities.

3. Increasing Need for Minimally Invasive Surgical Methods: The rising interest in minimally invasive surgical techniques is fueling the demand for injectable and easily deliverable bone graft products that can be used to repair bone with minimum surgical trauma.

4. Increasing Awareness of the Shortcomings of Autografts: Although autografts are the gold standard, their shortcomings, including donor site morbidity and restricted availability, are stimulating the need for efficient allograft and synthetic substitutes.

5. Growing Emphasis on Regenerative Medicine: The general trend towards regenerative medicine and the need to restore tissue function instead of merely replacing it are driving the demand for bone defect repair materials that actively stimulate bone regeneration.

Challenges in the bone defeat repair material market are:

1. Exorbitant Price of Advanced Materials and Cell-Based Therapies: The price of advanced synthetic bone grafts, growth factors, and cell-based therapies can be quite high, restricting their availability and adoption, especially in cost-conscious markets.

2. Complicated Regulatory Routes for New Products: The process of obtaining regulatory approval for new bone defect repair materials, particularly those involving biologics or new technologies, is long, complicated, and costly, discouraging innovation and market entry.

3. Clinical Complexity of Obtaining Consistent Bone Regeneration: Obtaining consistent and complete bone regeneration in large or complex defects, and in comorbid patients, is still a major clinical challenge, affecting the perceived effectiveness and uptake of some materials.

The market for bone defeat repair material is fueled by demographic changes, advances in technology, the need for minimally invasive treatments, the limitations of autografts, and the emphasis on regenerative medicine. Nevertheless, issues of high cost of cutting-edge therapies, rigorous regulatory processes, and the clinical difficulty of bone regeneration must be overcome to provide wider access to and effective use of these valuable medical materials.

List of Bone Defeat Repair Material Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies bone defeat repair material companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the bone defeat repair material companies profiled in this report include-

• Stryker
• Medtronic
• Johnson & Johnson
• Olympus Terumo Biomaterials
• NovaBone Products
• Biocomposites
• Tianjin Sannie Bioengineering Technology
• ALLGENS MEDICAL
• Jiangsu Yenssen Biotech
• Shanghai Rebone Biomaterials

Bone Defeat Repair Material Market by Segment

The study includes a forecast for the global bone defeat repair material market by type, application, and region.

Bone Defeat Repair Material Market by Type [Value from 2019 to 2031]:

• Autologous Bone
• Natural Bone
• Artificial Bone

Bone Defeat Repair Material Market by Application [Value from 2019 to 2031]:

• Neurosurgery
• Dentistry
• Orthopedics
• Others

Bone Defeat Repair Material Market by Region [Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Bone Defeat Repair Material Market

The bone defeat repair material market is an evolving sector with a mission to treat bone loss caused by trauma, surgery, infection, or disease. Recent trends have seen a trend towards biomimetic and bioactive materials that not only restore bone defects but actively stimulate bone regeneration. Advances in synthetic bone grafts, growth factor delivery systems, and cell-based therapies are broadening the treatment modalities available to surgeons. This introduction sets the stage to explore the specific advancements and changes occurring in key global markets for bone defect repair materials.

• United States: The US market is also experiencing noteworthy advancements in synthetic bone graft materials with a focus on incorporating growth factors and bioactive agents to further enhance osteoconductive and osteoinductivity. Interest is also on the rise and clinical practice involving allograft and xenograft materials that are processed with enhanced sterilization methods for better safety. Additionally, the investigation of cell-based therapies and 3D-printed scaffolds for tailored bone regeneration is increasingly being developed.
• China: China's bone defect repair material market is growing at a fast pace due to rising surgical volumes and heightened focus on high-end medical technology. New developments include the rise in domestic production of synthetic bone grafts and the expanding use of allograft materials. There is also a growing interest in research and development in tissue engineering and in the application of principles of traditional Chinese medicine to bone regeneration therapy.
• Germany: Germany's market is dominated by a heavy focus on evidence-based and high-quality medical devices. Some recent advancements have involved optimizing synthetic bone graft compositions with better porosity and degradation patterns to closely match the characteristics of natural bone. Considerable work has also gone into researching bioactive glass and calcium phosphate ceramics and clinical use of growth factor-optimized autologous bone grafts.
• India: India's bone defect repair material market is changing, with a combination of conventional and high-tech materials being used. Some recent trends are the growing accessibility of low-cost synthetic bone grafts and enhanced awareness of the advantages of allograft materials in specialized surgery centers. Increasing interest in indigenous research on natural biomaterials and tissue engineering strategies for bone regeneration is also seen.
• Japan: Japan's market has a high standard for safety and biocompatibility in medical devices. The latest advances in materials for the repair of bone defects involve the introduction of high-porosity synthetic bone grafts with controlled degradation rates. There has also been high emphasis on research in cell-seeded scaffolds and the use of growth factors for the stimulation of bone regeneration, especially in difficult non-union fractures and large bone defects.

Features of the Global Bone Defeat Repair Material Market

• Market Size Estimates: Bone defeat repair material market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
• Segmentation Analysis: Bone defeat repair material market size by type, application, and region in terms of value ($B).
• Regional Analysis: Bone defeat repair material market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the bone defeat repair material market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the bone defeat repair material market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the bone defeat repair material market by type (autologous bone, natural bone, and artificial bone), application (neurosurgery, dentistry, orthopedics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Bone Defeat Repair Material Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: PESTLE Analysis
• 2.4: Patent Analysis
• 2.5: Regulatory Environment
• 2.6: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Bone Defeat Repair Material Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Bone Defeat Repair Material Market by Type
  • 3.3.1: Autologous Bone: Trends and Forecast (2019 to 2031)
  • 3.3.2: Natural Bone: Trends and Forecast (2019 to 2031)
  • 3.3.3: Artificial Bone: Trends and Forecast (2019 to 2031)
• 3.4: Global Bone Defeat Repair Material Market by Application
  • 3.4.1: Neurosurgery: Trends and Forecast (2019 to 2031)
  • 3.4.2: Dentistry: Trends and Forecast (2019 to 2031)
  • 3.4.3: Orthopedics: Trends and Forecast (2019 to 2031)
  • 3.4.4: Others: Trends and Forecast (2019 to 2031)

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Bone Defeat Repair Material Market by Region
• 4.2: North American Bone Defeat Repair Material Market
  • 4.2.1: North American Market by Type: Autologous Bone, Natural Bone, and Artificial Bone
  • 4.2.2: North American Market by Application: Neurosurgery, Dentistry, Orthopedics, and Others
  • 4.2.3: The United States Bone Defeat Repair Material Market
  • 4.2.4: Mexican Bone Defeat Repair Material Market
  • 4.2.5: Canadian Bone Defeat Repair Material Market
• 4.3: European Bone Defeat Repair Material Market
  • 4.3.1: European Market by Type: Autologous Bone, Natural Bone, and Artificial Bone
  • 4.3.2: European Market by Application: Neurosurgery, Dentistry, Orthopedics, and Others
  • 4.3.3: German Bone Defeat Repair Material Market
  • 4.3.4: French Bone Defeat Repair Material Market
  • 4.3.5: Spanish Bone Defeat Repair Material Market
  • 4.3.6: Italian Bone Defeat Repair Material Market
  • 4.3.7: The United Kingdom Bone Defeat Repair Material Market
• 4.4: APAC Bone Defeat Repair Material Market
  • 4.4.1: APAC Market by Type: Autologous Bone, Natural Bone, and Artificial Bone
  • 4.4.2: APAC Market by Application: Neurosurgery, Dentistry, Orthopedics, and Others
  • 4.4.3: Japanese Bone Defeat Repair Material Market
  • 4.4.4: Indian Bone Defeat Repair Material Market
  • 4.4.5: Chinese Bone Defeat Repair Material Market
  • 4.4.6: South Korean Bone Defeat Repair Material Market
  • 4.4.7: Indonesian Bone Defeat Repair Material Market
• 4.5: ROW Bone Defeat Repair Material Market
  • 4.5.1: ROW Market by Type: Autologous Bone, Natural Bone, and Artificial Bone
  • 4.5.2: ROW Market by Application: Neurosurgery, Dentistry, Orthopedics, and Others
  • 4.5.3: Middle Eastern Bone Defeat Repair Material Market
  • 4.5.4: South American Bone Defeat Repair Material Market
  • 4.5.5: African Bone Defeat Repair Material Market

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Bone Defeat Repair Material Market by Type
  • 6.1.2: Growth Opportunities for the Global Bone Defeat Repair Material Market by Application
  • 6.1.3: Growth Opportunities for the Global Bone Defeat Repair Material Market by Region
• 6.2: Emerging Trends in the Global Bone Defeat Repair Material Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Bone Defeat Repair Material Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Bone Defeat Repair Material Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Stryker
  • Company Overview
  • Bone Defeat Repair Material Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.2: Medtronic
  • Company Overview
  • Bone Defeat Repair Material Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.3: Johnson & Johnson
  • Company Overview
  • Bone Defeat Repair Material Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.4: Olympus Terumo Biomaterials
  • Company Overview
  • Bone Defeat Repair Material Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.5: NovaBone Products
  • Company Overview
  • Bone Defeat Repair Material Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.6: Biocomposites
  • Company Overview
  • Bone Defeat Repair Material Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.7: Tianjin Sannie Bioengineering Technology
  • Company Overview
  • Bone Defeat Repair Material Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.8: ALLGENS MEDICAL
  • Company Overview
  • Bone Defeat Repair Material Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.9: Jiangsu Yenssen Biotech
  • Company Overview
  • Bone Defeat Repair Material Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.10: Shanghai Rebone Biomaterials
  • Company Overview
  • Bone Defeat Repair Material Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing